The Europe Center invites the Stanford and area community to join us Friday, May 4th, for a roundtable discussion on the upcoming French elections.    (Sign-up here [link]).  Three analysts from different fields of expertise – Arthur Goldhammer, Laurent Cohen-Tanugi, and Jimia Boutouba – will discuss the election and its wider context.  The Europe Center is timing this public event  for the eve of round 2, with much to analyze from round 1, and policy options to consider for the impending winner.

Round 1 (April 22) results:

• François Hollande: 28.6%
• Nicolas Sarkozy 27.2%
• Marine Le Pen 17.9%
• Jean-Luc Melenchon 11.1%
• François Bayrou 9.1%
• Five other candidates 6.1%

Speculation during the two-week interim period between round 1 and 2 will focus on the leader of the far-right Front National – Marine Le Pen, who took her party to its highest vote tally in modern memory.  How will the two remaining candidates vie for these voters who were apparently preoccupied with a perceived threat from immigration, cultural dilution, and security?  Especially in the wake of the recent tragic violence in Toulouse, candidate Sarkozy courted such far-right voters, but candidate Hollande vociferously chastised the tactic as capitalizing on the tragedy.

Available opinion surveys note widespread disenchantment with incumbent President Nicolas Sarkozy, who has put his personal stamp on Euro-zone rescue and recovery and alliance with German Chancellor Angela Merkel, but who has failed to deliver such reform, stability, or growth in France.  President Sarkozy has also raised the profile of France and its international policy on the Afghan international peace-keeping force, as well as the Arab Spring and most recently international effort to enforce a cease fire in Syria.

French voters also express disappointment with Socialist candidate François Hollande, frequently labeling him and his party as vaguely center-right and having abandoned a clear commitment to the party’s traditional platform of equality and social justice.
Interest – and survey support – grew in the run-up to the first round of voting for the candidate Jean-Luc Mélenchon, who brings a background as a teacher and self-identified Trotskyite, to lead the party Front de Gauche – a loose coalition of ex-Communists, environmental left, and the rough equivalent of U.S. “99%” movement.  

What did not happen this year was to have an “alternative” candidates from what are seen as the edges of ideological spectrum can win enough votes to edge out Sarkozy or Hollande and survive to the second round – as happened in 2002 when Jean-Marie Le Pen (father of Marine) out-placed the Socialist Lionel Jospin, to make it to the second round, and effectively compel center-left Socialists to hand the election to Jacques Chirac.
***************

The French presidential election is organized to accommodate two rounds.  The first round took place Sunday, April 22.  Because no candidate won more than fifty percent of the vote, there will be a run-off election of the top two candidates, on Sunday, May 6.
Basic facts of the structure of the French Presidential election are at:
http://www.heraldtribune.com/article/20120420/API/1204200768?p=1&tc=pg

Latest blog entry by Arthur Goldhammer: http://artgoldhammer.blogspot.com/

Opinion poll results from the leading agency Ipsos Public Affairs are updated frequently at: http://www.ipsos.fr/presidentielle-2012/index.php

A once-a-day pill to help prevent HIV infection could significantly reduce the spread of AIDS, but only makes economic sense if used in select, high-risk groups, Stanford researchers conclude in a new study.

The researchers looked at the cost-effectiveness of the combination drug tenofovir-emtricitabine, which was found in a landmark 2010 trial to reduce an individual’s risk of HIV infection by 44 percent when taken daily. Patients who were particularly faithful about taking the drug reduced their risk to an even greater extent – by 73 percent.

The results generated so much interest that the Stanford researchers decided to see if it would be cost-effective to prescribe the pill daily in large populations, a prevention technique known as pre-exposure prophylaxis, or PrEP.

They created an economic model focused on gay men, as they account for more than half of the estimated 56,000 new infections annually in the United States, according to the Centers for Disease Control and Prevention.

“Promoting PrEP to all men who have sex with men could be prohibitively expensive,” said Jessie Juusola, a PhD candidate in management science and engineering in the School of Engineering and first author of the study. “Adopting it for men who have sex with men at high risk of acquiring HIV, however, is an investment with good value that does not break the bank.”

For instance, using the pill in the general population of gay men would cost $495 billion over 20 years, compared to $85 billion when targeted to those at particularly high risk, the researchers found. The study will be published in the April 17 issue of the Annals of Internal Medicine.

Senior author Eran Bendavid, an affiliate of Stanford Health Policy at the Freeman Spogli Institute, said the results are a departure from a previous study. Earlier research found PrEP was not cost-effective when compared with other commonly accepted prevention programs.

The new Stanford study differs in a few important respects, taking into consideration the decline in transmission rates over time as more individuals take the pill. The Stanford team also assumed individuals would stop taking PrEP after 20 years, not stay on the drug for life, as the previous study had assumed.

The pill combination, marketed under the brand name Truvada, is widely used for treating HIV infection. But it wasn’t until a landmark trial, published in the New England Journal of Medicine in November 2010, that individuals and their doctors began to seriously consider using the drug as a preventive therapy. The drug’s maker, Foster City, Calif.-based Gilead Sciences Inc., has filed a supplemental new drug application to market it for prevention purposes.

The CDC issued interim guidelines on the drug’s use in January 2011, suggesting that if practitioners prescribe it as a preventive measure, they regularly monitor patients for side effects and counsel them about adherence, condom use and other methods to reduce their risk of infection.

In developing their model, the Stanford researchers took into account the cost of the drug – about $26 a day, or almost $10,000 a year – as well as the expenses for physician visits, periodic monitoring of kidney function affected by the drug, and regular testing for HIV and sexually transmitted diseases.

“We’re talking about giving uninfected people a drug that has some toxicities, so it’s crucial to have them monitored regularly,” said Bendavid, who is an assistant professor of medicine in Stanford’s School of Medicine.

Without PrEP, the researchers calculated there would be more than 490,000 new infections among gay men in the United States in the next 20 years. If just 20 percent of these men took the pill daily, there would be nearly 63,000 fewer infections.

However, the costs are substantial. Use of the drug by 20 percent of gay men would cost $98 billion over 20 years; if every man in this group took PrEP for 20 years, the costs would be a staggering $495 billion.

Given these figures, the researchers looked at the option of giving PrEP only to men who are at high risk – those who have five or more sexual partners in a year. If just 20 percent of these high-risk individuals took the drug, 41,000 new infections would be prevented over 20 years at a cost of about $16.6 billion.

At less than $50,000 per quality-adjusted life year gained (a measure of how long people live and their quality of life), that strategy represents relatively good value, according to Juusola.

“However, even though it provides good value, it is still very expensive,” she said. “In the current health care climate, PrEP’s costs may become prohibitive, especially given the other competing priorities for HIV resources, such as providing treatment for infected individuals.”

She said the costs could be significantly reduced if the pill is found to be effective when used intermittently, rather than on a daily basis. Current trials are examining the effectiveness of the drug when used less often.

Other co-authors are Margaret L. Brandeau, the Coleman F. Fung Professor of Engineering, and Douglas K. Owens, the Henry J. Kaiser, Jr. Professor at Stanford and senior investigator at the Veterans Affairs Palo Alto Health Care System. Owens also is director of Stanford’s Center for Health Policy and Center for Primary Care and Outcomes Research.

The study was funded by the National Institutes of Health and the Department of Veterans Affairs and supported by Stanford’s departments of Medicine and Management Science and Engineering.

International Scholars in Residence at the Humanities Center 2012-2013

Distinguished scholars from Egypt, New Zealand, South Africa, and Turkey have been chosen as joint Stanford Humanities Center/FSI international visitors.

The Stanford Humanities Center and the Freeman Spogli Institute for International Studies (FSI) are pleased to announce that four international scholars have been chosen to come to Stanford in 2012-13 as part of a jointly sponsored international program entering its fourth year. Nominated by Stanford departments and research centers, the international scholars will be on campus for four-week residencies. They will have offices at the Humanities Center and will be affiliated with their nominating unit, the Humanities Center, and FSI.

A major purpose of the residencies is to bring high-profile international scholars into the intellectual life of the university, targeting scholars whose research and writing engage with the missions of both the Humanities Center and FSI.

The following scholars have been selected for the upcoming academic year:

Maha Abdel-Rahman (April 2013) is a Lecturer in Development Studies at the University of Cambridge, and an Egyptian academic and activist. She holds a PhD from the Dutch Institute of Social Studies. While at Stanford, she will research the relationship between social movements and civil society in Egypt, and will give seminars based on her book project, On Protest Movements and Uprisings: Egypt’s Permanent Revolution. She was nominated by the Abbasi Program in Islamic Studies.

Mohamed Adhikari (May 2013) is an Associate Professor in the Historical Studies Department at the University of Cape Town, South Africa.

Mohamed Adhikari (May 2013) is an Associate Professor in the Historical Studies Department at the University of Cape Town, South Africa. He will explore the relationship between European settler colonialism and genocide in hunter-gatherer societies, and will bring to campus a comparative perspective on genocide, race, identity and language. His latest publication, The Anatomy of a South African Genocide: The Extermination of the Cape San Peoples (2010) was the first to deal with the topic of genocide in the South African context. He will also present from his edited book, Invariably Genocide?: When Hunter-gatherers and Commercial Stock Farmers Clash, due for publication in 2013. He was nominated by the Center for African Studies.

Nuray Mert (October 2012) is an Associate Professor of Political Science and International Relations at Istanbul University. She is a political observer and contributor to Turkey’s major newspapers (Milliyet and Hûrriyet Daily News), one of the few contemporary Turkish public intellectuals with an academic background and a journalist’s investigative mind. An outspoken critic on sensitive issues in the Turkish context such as rights of minorities (the Kurdish Question), freedom of religion and of press, she will lecture on the geopolitical implications of the Arab Spring for Turkey and the Middle East, and on Turkey’s accession to the European Union in light of the financial crisis of the Euro-zone. She was nominated by the Mediterranean Studies Forum.

Te Maire Tau (February 2013) is an Associate Professor of History at the University of Canterbury in New Zealand.

In addition to the jointly-sponsored program with FSI, the Humanities Center will also bring international visitors from France and India as part of the international programs at the Humanities Center.

Denis Lacorne (January 2013) is a prominent French public intellectual and Professor of Political Science at CERI (Centre d’Etudes et de Recherches Internationales) Sciences Po in Paris. Lacorne will give presentations on French and American notions of religious toleration, deriving from his latest book on US and French secularism which demonstrates that, despite some striking similarities between US secularism and French laïcité, the secularization of French society has followed a different path from that of American society. He was nominated by the French Culture Workshop, and the History Department.

Himanshu Prabha Ray (April 2013) is an historian of Ancient India at Jawaharlal Nehru University in New Delhi, where she works in the fields of ancient India and maritime archaeology. During her residency, she will discuss and finalize her current book project, Return of the Buddha:  Ancient symbols for modern India, as well as her research on the creation of a public discourse around Buddhism in the colonial and post-colonial period in India. The Buddha, in her account, is not statically located in history, but rather contested within settings of colonialism, post-colonialism and nation-building. She was nominated by the Classics Department, with the support of the Department of Religious Studies, the Center for South Asia, the Ho Center for Buddhist Studies, and the Archaeology Center.

While at Stanford, the scholars will offer informal seminars and public lectures and will also be available for consultations with interested faculty and students. For additional information, please contact Marie-Pierre Ulloa, mpulloa@stanford.edu.

Relevant URLs:

Stanford Humanities Center

http://shc.stanford.edu/

Contact:

Marie-Pierre Ulloa

Senior Executive Officer for International Programs

Stanford Humanities Center

(650) 724 8106, mpulloa@stanford.edu